Table 1.
Cytotoxic activity (IC50) of compounds 1–4 against MCF-7, HCT-116, HepG2 and WI-38 cell lines.
Compounds | * Cytotoxic Activity IC50
a (μM) |
|||
---|---|---|---|---|
MCF-7 | HCT-116 | HepG2 | WI-38 | |
1 | 26.8 ± 2.20 | 27.2 ± 1.11 | 28.8 ± 2.25 | 30.0 ± 1.20 |
2 | 21.6 ± 1.8 | 22.2 ± 1.5 | 25.5 ± 2.17 | 40.50 ± 2.25 |
3a | 17.0 ± 1.80 | 15.2 ± 2.32 | 19.2 ± 1.50 | 38.23 ± 2.10 |
3b | 18.50 ± 2.11 | 15.6 ± 3.15 | 19.4 ± 2.19 | 39.13 ± 1.30 |
3c | 18.9 ± 2.00 | 16.3 ± 4.16 | 19.9 ± 2.06 | 37.42 ± 1.49 |
3d | 19.2± 2.35 | 16.6 ± 1.27 | 20.2 ± 2.33 | 35.26 ± 2.42 |
3e | 19.8 ± 2.70 | 16.2 ± 1.15 | 20.4 ± 2.30 | 40.01 ± 2.31 |
3f | 10.7 ± 2.30 | 10.20 ± 1.18 | 10.6 ± 2.32 | 29.82 ± 1.51 |
3g | 9.0 ± 2.40 | 8.5 ± 2.30 | 10.0 ± 2.46 | 30.01 ± 3.72 |
3h | 10.2 ± 2.01 | 10.11 ± 2.45 | 10.4 ± 2.08 | 28.10 ± 4.22 |
4a | 11.2 ± 4.31 | 12.3 ± 2.17 | 17.0 ± 4.30 | 38.03 ± 5.51 |
4b | 11.6 ± 3.22 | 12.6 ± 1.05 | 18.0 ± 3.20 | 39.8 ± 4.51 |
4c | 12.3 ± 4.08 | 13.2 ± 1.03 | 18.5 ± 4.38 | 29.5 ± 4.02 |
4d | 12.6 ± 1.70 | 13.6 ± 1.09 | 18.7 ± 1.20 | 29.9 ± 3.63 |
4e | 14.2 ± 0.74 | 13.7 ± 0.55 | 18.62 ± 0.94 | 20.24 ± 5.52 |
4f | 8.01 ± 1.83 | 8.02 ± 0.26 | 8.9 ± 1.73 | 19.33 ± 5.87 |
4g | 5.1 ± 1.14 | 5.02± 1.19 | 6.6 ± 1.40 | 16.32 ± 3.21 |
4h | 6.6 ± 1.28 | 7.02 ± 0.46 | 7.5 ± 1.29 | 18.12 ± 2.06 |
5-FU | 5.38 ± 0.24 | 7.88 ± 0.2 | 5.34 ± 0.4 | 5.70 ± 1.50 |
erlotinib | 6.65 ± 0.82 | 7.49 ± 0.65 | nd | 22.50 ± 0.65 |
* Three independent experiments were performed for each concentration. a IC50 values represent mean ± SD of three experiments.